Karkhanis, A. V., Harwood, M. D., Stader, F., Bois, F. Y., & Neuhoff, S. (2024). Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK Framework. Pharmaceutics, 16(10), 1284-1305. https://doi.org/10.3390/pharmaceutics16101284

Karkhanis, Aneesh V., Matthew D. Harwood, Felix Stader, Frederic Y. Bois, and Sibylle Neuhoff. "Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated Within a PBPK Framework." Pharmaceutics 16, no. 10 (2024): 1284-1305. https://doi.org/10.3390/pharmaceutics16101284.

Karkhanis, Aneesh V., et al. "Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated Within a PBPK Framework." Pharmaceutics, vol. 16, no. 10, 2024, pp. 1284-1305, https://doi.org/10.3390/pharmaceutics16101284.